 Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z | | The end of the list has been reached or no journals were found for your choice. |
|
|
- Dissecting operant alcohol self‐administration using
saccharin‐fading procedure
Authors: Javier Calleja‐Conde; Víctor Echeverry‐Alzate, Kora‐Mareen Bühler, Jose Ángel Morales‐García, Lucía Segovia‐Rodríguez, Pedro Durán‐González, Pedro Olmos, Fernando Rodríguez Fonseca, Elena Giné, Jose Antonio López‐Moreno
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-02-02T02:43:46-08:00
DOI: 10.1002/npr2.12289
- Development and validation of the Japanese version of EPDS‐P for
indirect screening of paternal perinatal depression based on maternal
reporting: Protocol for a prospective longitudinal observational study
Authors:
Keita Tokumitsu; Norio Yasui‐Furukori,
Sheehan David Fisher,
Takako Keta,
Chihiro Yamada,
Junko Takeuchi,
Koji Yachimori,
Norio Sugawara,
Kazutaka Shimoda
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-25T11:23:41-08:00
DOI: 10.1002/npr2.12321
- Predictor role of marital conflict on maternal competency with mediating
role of perceived stress and concerns during pregnancy: A structural
equation model
Authors:
Sepideh Mohammad Alipour; Mitra Rahimzadeh,
Zahra Mehdizadeh Tourzani,
Zohreh Mahmoodi,
Sara Esmaelzadeh Saeieh
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-24T07:04:20-08:00
DOI: 10.1002/npr2.12309
- A case of musical hallucinations induced by tramadol
Authors:
Tatsu Hase; Norio Yasui‐Furukori,
Shigeki Yamaguchi,
Kazutaka Shimoda
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-19T01:25:10-08:00
DOI: 10.1002/npr2.12320
- A case of schizophrenia with relapsed catatonia successfully treated with
blonanserin transdermal patch
Authors:
Minako Hagikura; Toshiya Inada
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-18T12:00:00-08:00
DOI: 10.1002/npr2.12314
- Synergistic anti‐depressive effect of combination treatment of
Brexpiprazole and selective serotonin reuptake inhibitors on forced
swimming test in mice
Authors:
Naoki Amada; Tsuyoshi Hirose,
Mikio Suzuki,
Yusuke Kakumoto,
Takashi Futamura,
Kenji Maeda,
Tetsuro Kikuchi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-17T05:37:39-08:00
DOI: 10.1002/npr2.12316
- Bidirectional effects of voluntary exercise on the expression of Bdnf
isoforms in the hippocampus of Hatano rat strains displaying different
activity levels
Authors:
Shuichi Chiba; Hikaru Asano,
Shogo Moriya,
Taichi Hatakeyama,
Shohei Kobayashi,
Ryo Ohta,
Maiko Kawaguchi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-17T04:45:01-08:00
DOI: 10.1002/npr2.12313
- Post‐therapy plasma concentrations of quetiapine in Taiwanese
patients
Authors:
Cho‐Yin Huang; Yen‐Feng Lin,
Chia‐Ru Chen,
Shih‐Ku Lin
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-16T08:28:26-08:00
DOI: 10.1002/npr2.12303
- A diagnostic test to examine early improvement as a predictor of later
response to lurasidone in bipolar depression
Authors:
Taro Kishi; Hiroshi Nakamura,
Tadafumi Kato,
Nakao Iwata
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-12T12:38:48-08:00
DOI: 10.1002/npr2.12319
- The potential beneficial effect of sleep deprivation following traumatic
events to preventing PTSD: Review of current insight regarding sleep,
memory, and trauma resonating with ancient rituals—Àìsùn Oku
(African) and Tsuya (Japanese)
Authors:
Hagit Cohen; Olusola T. Ephraim‐Oluwanuga,
Orunmuyi T. Akintunde,
Oye Gureje,
Michael A. Matar,
Doron Todder,
Joseph Zohar
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-09T05:03:15-08:00
DOI: 10.1002/npr2.12311
- Analysis of the effect of brexpiprazole on sleep architecture in patients
with schizophrenia: A preliminary study
Authors:
Yusuke Arai; Daimei Sasayama,
Kazuaki Kuraishi,
Shiho Murata,
Nobuteru Usuda,
Mika Tsuchida,
Yuka Nakajima,
Shinsuke Washizuka
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2023-01-06T12:44:11-08:00
DOI: 10.1002/npr2.12317
- Issue Information
Abstract: Neuropsychopharmacology Reports, Volume 42, Issue 4, Page 397-397, December 2022.
PubDate: 2022-12-22T04:22:05-08:00
DOI: 10.1002/npr2.12187
Issue No: Vol. 42, No. 4 (2022)
- The management challenges of a case with Flupentixol‐induced
neuroleptic malignant syndrome
Authors:
Forouzan Elyasi; Seyedehnasibeh sadati,
Fateme Heydari
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-30T08:24:00-08:00
DOI: 10.1002/npr2.12315
- Age at onset of alcohol consumption and its association with alcohol
misuse in adulthood
Authors:
Soo Y. Kim; Sung H. Jeong,
Eun‐Cheol Park
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-28T04:24:25-08:00
DOI: 10.1002/npr2.12302
- Attention‐deficit hyperactivity symptoms and risk of alcohol use
relapse
Authors:
Takahiro Kawata; Genichi Sugihara,
Yoichi Kakibuchi,
Midori Tomitaka,
Miho Miyajima,
Eisuke Matsushima,
Takashi Takeuchi,
Hidehiko Takahashi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-26T08:53:33-08:00
DOI: 10.1002/npr2.12312
- Risk factors for cannabis use disorders and cannabis psychosis in Japan:
Second report of a survey on cannabis‐related health problems among
community cannabis users using social networking services
Authors: Yuji Masataka; Takeshi Sugiyama, Yoshiyuki Akahoshi, Toshihiko Matsumoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-19T11:39:54-08:00
DOI: 10.1002/npr2.12307
- The positive allosteric modulator of NMDA receptors, GNE‐9278, blocks
the ethanol‐induced decrease of excitability in developing retrosplenial
cortex neurons from mice
Authors: Clark W. Bird; Carlos F. Valenzuela
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-15T11:20:06-08:00
DOI: 10.1002/npr2.12306
- A case of postpsychotic depression improved by switching antipsychotic
monotherapy
Authors: Yoshiyo Oguchi; Atsuo Nakagawa, Hiroki Kocha
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-12-08T11:38:46-08:00
DOI: 10.1002/npr2.12308
- Satisfaction with web‐based courses on clinical practice guidelines for
psychiatrists: Findings from the “Effectiveness of Guidelines for
Dissemination and Education in Psychiatric Treatment (EGUIDE)” project
Authors: Hitoshi Iida; Tsuyoshi Okada, Kiyotaka Nemoto, Naomi Hasegawa, Shusuke Numata, Kazuyoshi Ogasawara, Kenichiro Miura, Junya Matsumoto, Hikaru Hori, Jun‐ichi Iga, Kayo Ichihashi, Naoki Hashimoto, Hisashi Yamada, Kazutaka Ohi, Norio Yasui‐Furukori, Kentaro Fukumoto, Takashi Tsuboi, Masahide Usami, Ryuji Furihata, Yoshikazu Takaesu, Akitoyo Hishimoto, Hiroyuki Muraoka, Eiichi Katsumoto, Tatsuya Nagasawa, Shinichiro Ochi, Hiroshi Komatsu, Saya Kikuchi, Masahiro Takeshima, Toshiaki Onitsuka, Shinichiro Tamai, Chika Kubota, Ken Inada, Koichiro Watanabe, Hiroaki Kawasaki, Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-28T10:40:52-08:00
DOI: 10.1002/npr2.12300
- Preliminary analysis of hippocampus synaptic apoptosis and microglial
phagocytosis induced by severe restraint stress
Authors:
Shingo Enomoto; Masahiro Ohgidani,
Noriaki Sagata,
Shogo Inamine,
Takahiro A. Kato
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-23T10:43:55-08:00
DOI: 10.1002/npr2.12298
- Plasma neuropeptide levels in patients with schizophrenia, bipolar
disorder, or major depressive disorder and healthy controls: A multiplex
immunoassay study
Authors: Shinsuke Hidese; Fuyuko Yoshida, Ikki Ishida, Junko Matsuo, Kotaro Hattori, Hiroshi Kunugi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-22T06:18:47-08:00
DOI: 10.1002/npr2.12304
- The effect of peer education compared to education provided by healthcare
providers on premenstrual syndrome in high school students: A social
network‐based quasi‐experimental controlled trial
Authors: Farzaneh Babapour; Forouzan Elyasi, Monirolsadate Hosseini‐Tabaghdehi, Jamshid Yazdani‐Charati, Zohreh Shahhosseini
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-21T07:48:26-08:00
DOI: 10.1002/npr2.12305
- Development of an individual fitness score (IFS) based on the depression
treatment guidelines of in the Japanese Society of Mood Disorders
Authors: Kentaro Fukumoto; Fumitoshi Kodaka, Naomi Hasegawa, Hiroyuki Muraoka, Hikaru Hori, Kayo Ichihashi, Yuka Yasuda, Hitoshi Iida, Kazutaka Ohi, Shinichiro Ochi, Kenta Ide, Naoki Hashimoto, Masahide Usami, Toshinori Nakamura, Hiroshi Komatsu, Tsuyoshi Okada, Tatsuya Nagasawa, Ryuji Furihata, Kiyokazu Atake, Mikio Kido, Saya Kikuchi, Hirotaka Yamagata, Taishiro Kishimoto, Manabu Makinodan, Tadasu Horai, Masahiro Takeshima, Chika Kubota, Takeshi Asami, Eiichi Katsumoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Norio Yasui‐Furukori, Koichiro Watanabe, Ken Inada, Kotaro Otsuka, Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-16T11:39:35-08:00
DOI: 10.1002/npr2.12301
- Predictors of response to pharmacotherapy in children and adolescents with
psychiatric disorders: A combined post hoc analysis of four clinical trial
data
Authors: Takashi Tsujii; Hitoshi Sakurai, Hiroyoshi Takeuchi, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-03T11:40:28-07:00
DOI: 10.1002/npr2.12299
- Risk assessment of accidental falls in patients taking trazodone,
quetiapine, or risperidone for insomnia: A single‐center, case–control
study
Authors: Yoshihito Shimizu; Masatoshi Taga, Yoshimitsu Takahashi, Yasuhiko Yamamoto, Togen Masauji
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-11-02T03:43:45-07:00
DOI: 10.1002/npr2.12297
- Adolescent cannabis use and the later onset of bipolar disorder: protocol
Authors:
Naonori Yasuma; Kotaro Imamura,
Kazuhiro Watanabe,
Mako Iida,
Ayumi Takano
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-10-25T10:53:50-07:00
DOI: 10.1002/npr2.12296
- Development of individual fitness score for conformity of prescriptions to
the “Guidelines For Pharmacological Therapy of Schizophrenia”
Authors: Ken Inada; Kentaro Fukumoto, Naomi Hasegawa, Yuka Yasuda, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Hitoshi Iida, Kazutaka Ohi, Hiroyuki Muraoka, Fumitoshi Kodaka, Kenta Ide, Naoki Hashimoto, Jun‐ichi Iga, Kazuyoshi Ogasawara, Kiyokazu Atake, Yoshikazu Takaesu, Tatsuya Nagasawa, Hiroshi Komatsu, Tsuyoshi Okada, Ryuji Furihata, Mikio Kido, Saya Kikuchi, Chika Kubota, Manabu Makinodan, Shinichiro Ochi, Masahiro Takeshima, Hirotaka Yamagata, Junya Matsumoto, Kenichiro Miura, Masahide Usami, Taishiro Kishimoto, Toshiaki Onitsuka, Eiichi Katsumoto, Akitoyo Hishimoto, Shusuke Numata, Norio Yasui‐Furukori, Koichiro Watanabe, Ryota Hashimoto
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-10-18T02:39:51-07:00
DOI: 10.1002/npr2.12293
- What outcomes in community mental health research are important to
caregivers of people with schizophrenia' An exploratory qualitative
analysis of an online survey
Authors: Naonori Yasuma; Takuma Shiozawa, Makoto Ogawa, Makiko Abe, Momoka Igarashi, Takayuki Kawaguchi, Sayaka Sato, Daisuke Nishi, Norito Kawakami, Sosei Yamaguchi, Chiyo Fujii
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-10-10T10:44:54-07:00
DOI: 10.1002/npr2.12295
- Association between functional recovery and medication adherence in
schizophrenia
Authors:
Junpei Ishii; Fumitoshi Kodaka,
Hisatsugu Miyata,
Wataru Yamadera,
Hikaru Seto,
Hidejiro Higuchi,
Yoshiaki Tsuruoka,
Masahiro Shigeta
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-10-05T12:39:22-07:00
DOI: 10.1002/npr2.12294
- Central monitoring of depression and anxiety symptoms reduces placebo
responses in depression clinical trials: A post hoc exploratory analysis
of data from the phase III CCT‐004 trial of vortioxetine
Authors:
Yoshinori Watanabe; Akira Nishimura,
Toshiaki Kikuchi,
Norifusa Sawada,
Manami Imazaki,
Isao Inada,
Koichiro Watanabe
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-09-24T12:44:08-07:00
DOI: 10.1002/npr2.12288
- Intracerebroventricular administration of oxytocin and intranasal
administration of the oxytocin derivative improve β‐amyloid peptide
(25–35)‐induced memory impairment in mice
Authors: Junpei Takahashi; Yudai Ueta, Daisuke Yamada, Sachie Sasaki‐Hamada, Takashi Iwai, Tomomi Akita, Chikamasa Yamashita, Akiyoshi Saitoh, Jun‐Ichiro Oka
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-09-19T12:34:41-07:00
DOI: 10.1002/npr2.12292
- The association between body image, emotional health, relationships, and
unhealthy dietary behaviors among medical sciences students: A structural
equation modeling analysis
Authors:
Hoda Arabi‐Mianrood; Zohreh Shahhosseini,
Monirolsadate Hosseini Tabaghdehi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-09-07T10:39:08-07:00
DOI: 10.1002/npr2.12291
- A preliminary study on predictors of treatment response to repetitive
transcranial magnetic stimulation in patients with treatment‐resistant
depression in Japan
Authors: Haruki Ikawa; Mamoru Tochigi, Yoshihiro Noda, Hiroshi Oba, Tatsuro Kaminaga, Keita Sakurai, Emi Ikebuchi, Naoki Hayashi, Hiroshi Kunugi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-08-30T02:43:17-07:00
DOI: 10.1002/npr2.12290
- Caffeine facilitates extinction of auditory fear conditioning in rats
Authors: Takaaki Ozawa; Kodai Kaseda, Yukio Ichitani, Kazuo Yamada
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-08-12T07:05:33-07:00
DOI: 10.1002/npr2.12287
- Recent findings on subjective well‐being and physical, psychiatric, and
social comorbidities in individuals with schizophrenia: A literature
review
Authors:
Yupeng He; Ayako Tanaka,
Taro Kishi,
Yuanying Li,
Masaaki Matsunaga,
Shinichi Tanihara,
Nakao Iwata,
Atsuhiko Ota
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-08-02T03:49:13-07:00
DOI: 10.1002/npr2.12286
- Topiramate and other kainate receptor antagonists for depression: A
systematic review of randomized controlled trials
Authors: Ahmad Shamabadi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-08-01T01:08:27-07:00
DOI: 10.1002/npr2.12284
- Simultaneous monitoring of activity and heart rate variability in
depressed patients: A pilot study using a wearable monitor for 3
consecutive days
Authors:
Norie Koga; Yoko Komatsu,
Ryo Shinozaki,
Ikki Ishida,
Yusuke Shimizu,
Sonoko Ishimaru,
Hiroshi Kunugi
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-07-29T11:38:00-07:00
DOI: 10.1002/npr2.12285
- Relationship among psychotic features, benzodiazepine receptor agonists,
and rehospitalization in patients with electroconvulsive
therapy‐responsive major depressive disorder: A retrospective 2‐year
observational study
Authors: Akise Umakoshi; Masahiro Takeshima, Yu Itoh, Mari Yamamoto, Nana Shibata, Masaya Ogasawara, Naoko Ayabe, Kazuo Mishima
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-07-22T02:02:56-07:00
DOI: 10.1002/npr2.12282
- Comparison of the efficacy and safety of quetiapine and lithium for
bipolar depression: A systematic review and meta‐analysis of randomized
controlled trials
Authors: Masaya Ogasawara; Masahiro Takeshima, Yuichi Esaki, Yoshiyuki Kaneko, Tomohiro Utsumi, Yumi Aoki, Norio Watanabe, Masahiro Suzuki, Yoshikazu Takaesu
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-07-20T05:20:04-07:00
DOI: 10.1002/npr2.12283
- Antidepressants for social anxiety disorder: A systematic review and
meta‐analysis
Authors: Nobuyuki Mitsui; Yutaka Fujii, Satoshi Asakura, Hissei Imai, Hisashi Yamada, Naoki Yoshinaga, Yoshihiro Kanai, Takeshi Inoue, Eiji Shimizu
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-07-18T04:46:14-07:00
DOI: 10.1002/npr2.12275
- Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer’s
disease and healthy controls in relation to the plasma P‐tau181 levels
in a Japanese sample
Authors: Shogyoku Bun; Sho Moriguchi, Toshiki Tezuka, Yoshiaki Sato, Keisuke Takahata, Morinobu Seki, Shinichiro Nakajima, Yasuharu Yamamoto, Yasunori Sano, Natsumi Suzuki, Ayaka Morimoto, Ryo Ueda, Hajime Tabuchi, Daisuke Ito, Masaru Mimura
Abstract: Neuropsychopharmacology Reports, EarlyView.
PubDate: 2022-07-17T05:25:07-07:00
DOI: 10.1002/npr2.12281
|
Open Access journal
